CLEC7A and ischemic stroke: Treatment of ischemic stroke with a Dectin-1 antagonist or a Syk inhibitor significantly decreased microglial activation, the brain infarct volume, neurological impairment, and production of the proinflammatory cytokines TNF-α and iNOS after ischemic stroke.